ANI Pharmaceuticals, Inc. ANIP
72.05 USD +0.80 (+1.12%)
Nov 11, 2026, 10:29 AM EST
70.65 Day range 71.88
67.41 52-week range 88.54
- YTD
- -8.73%
- 1 year
- -18.62%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 883.37M | 614.38M | 486.82M | 316.38M | 216.14M | |
| 542.06M | 364.17M | 305.30M | 177.60M | 115.53M | |
| 82.02M | -4.07M | 48.24M | -30.86M | -43.64M | |
| 78.34M | -18.52M | 18.78M | -47.90M | -42.60M | |
| 3.32 | -1.04 | 0.85 | -3.05 | -3.40 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 285.62M | 144.89M | 221.12M | 53.23M | 100.30M | |
| 1.44B | 1.28B | 904.42M | 760.09M | 771.60M | |
| 899.65M | 855.94M | 446.82M | 421.55M | 412.86M | |
| 617.03M | 624.09M | 285.67M | 286.52M | 287.37M | |
| 540.72M | 403.68M | 432.75M | 313.69M | 333.89M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 185.22M | 64.02M | 118.96M | -31.20M | 3.32M | |
| -34.32M | -404.72M | -18.51M | -15.74M | -105.48M | |
| -9.94M | 264.94M | 67.44M | -5.13M | 194.59M | |
| -13.84M | -2.72M | -8.87M | -8.13M | 92.00K | |
| 140.73M | -76.23M | 167.89M | -52.07M | 92.43M |